CClinicalTrials.gg
CompletedNCT05684822Updated Jan 13, 2023

The Effects of Acupuncture on Insomnia Among Midlife Women

An interventional study of Acupuncture in Menopause Syndrome, sponsored by National Cheng-Kung University Hospital. Completed at 1 site in Taiwan. Open to female participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-01-13.

Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Jan 2019, registered Oct 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
Female
01

Study summary

Aims: To explore the effects of acupuncture on the improvement of insomnia, fatigue, depression and menopausal symptoms among midlife women.

Read the detailed description

This research is a study with a randomized clinical trial. Participants were 40-60 years old with a sleep disturbance which persists more than one month. Twenty participants were randomly assigned into the experimental and control groups. The experimental group received acupuncture treatment (Taichong, Shenmen, Neiguan points) twice a week, total three weeks, plus sleep hygiene guidance; the control group received subcutaneous acupuncture (non-therapeutic acupuncture points) twice a week, total three weeks and given sleep Health guidance. All participants received pre-test and post-test, including sleep multiple physiological examination (PSG), Pittsburgh sleep quality table, Epworth sleepiness scale, hospital anxiety depression scale, menopausal symptom questionnaire, sleep disturbance comprehensive scale, and wore Actiwatch for three days. Data analysis was performed using SPSS.

02

Conditions studied

  • Menopause Syndrome

Keywords

  • Midlife Women
  • Acupuncture
  • Insomnia
  • Polysomnography
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 592 are open to participants now.

This study's enrollment of 42 is below the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

National Cheng-Kung University Hospital is the lead sponsor of 268 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women aged 40-60 years
  • Complaints of insomnia symptoms in the past month that lasted for at least one week, such as difficulty falling asleep, waking up easily in the middle of the night, unable to fall asleep after waking up, still not getting enough sleep after waking up in the morning
  • The score of sleep disorder on the Pittsburgh Sleep Quality Scale was more than 5 points

Exclusion criteria

Exclusion Criteria:

  • History of psychiatric disorders
  • History of sleep apnea or nocturnal myoclonus
  • Center or neurodegenerative disease
  • Cancer
  • Melatonin or sleeping pills use in the past month
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    The experimental group received acupuncture treatment

    The experimental group received acupuncture treatment (Taichong, Shenmen, Neiguan points) twice a week, total three weeks, plus sleep hygiene guidance

    Other: Acupuncture

  • Sham comparator
    The control group received subcutaneous sham acupuncture

    The control group received subcutaneous acupuncture (non-therapeutic acupuncture points) twice a week, total three weeks and given sleep Health guidance.

    Other: Acupuncture

Interventions

  • OtherAcupuncture

    Acupoint:Taichong, Shenmen, Neiguan points with twice a week for total three weeks

06

What researchers measure

Primary outcomes

  1. Pittsburgh sleep quality index (PSQI)

    The scale is suitable for the evaluation of sleep quality in patients with sleep disorders and mental disorders, as well as for the evaluation of sleep quality in general people.

    Time frame: 15 minutes

Secondary outcomes

  1. Hospital Anxiety and Depression Scale (HADS)

    The Hospital Anxiety and Depression Scale (HADS) is a self-assessment questionnaire that has been found to be a reliable instrument for detecting states of anxiety and depression in the setting of hospital outpatient clinic.

    Time frame: 15 minutes

  2. Epworth Sleepiness Scale (ESS)

    The ESS is a self-administered questionnaire with 8 questions. Respondents are asked to rate, on a 4-point scale (0-3), their usual chances of dozing off or falling asleep while engaged in eight different activities.

    Time frame: 15 minutes

  3. Snore Outcomes Survey (SOS)

    The SOS consists of 8 items relating to the intensity, duration, frequency, and impact of SDB symptoms - specifi cally snoring.

    Time frame: 15 minutes

  4. Global Physical Activity Questionnaire

    The Global Physical Activity Questionnaire was developed by WHO for physical activity surveillance in countries. It collects information on physical activity participation in three settings (or domains) as well as sedentary behaviour, comprising 16 questions (P1-P16)

    Time frame: 15 minutes

  5. Total sleep time (TST)

    TST was determined as the number of minutes asleep in bed after "lights off," considering only nighttime sleep.

    Time frame: 8 hours

  6. Wake time after sleep onset (WASO)

    Wake time after sleep onset is time during which one is awake.

    Time frame: 8 hours

  7. Sleep Latency

    Sleep latency, or sleep onset latency, is the time it takes a person to fall asleep after turning the lights out.

    Time frame: 8 hours

  8. Percentage of rapid eye movement (REM) stage

    REM sleep is the stage in which most people vividly dream. These periods of sleep typically start around 90 minutes after someone falls asleep.

    Time frame: 8 hours

  9. Sleep efficiency (SE)

    Sleep efficiency (SE), commonly defined as the ratio of total sleep time (TST) to time in bed (TIB), plays a central role in insomnia research and practice. The significance of SE is understandable because it captures a core problem for those suffering from insomnia-spending too much time in bed trying to sleep.

    Time frame: 8 hours

  10. Minimum spo2 level during sleep

    A normal level of oxygen is usually 95% or higher. Some people with chronic lung disease or sleep apnea can have normal levels around 90%.

    Time frame: 8 hours

  11. Mean heart rate during REM

    Rapid eye movement (REM) sleep is characterized by periods of profound cardiac autonomic activation evident in heart rate surges in humans and canines.

    Time frame: 8 hours

07

Study locations

1 site
  • Ministry of Health and Welfare Tainan Hospital
    Tainan, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05684822
Lead sponsor
National Cheng-Kung University Hospital
Responsible party
Sponsor
First posted
Jan 13, 2023
Start date
Jan 1, 2019
Primary completion
Aug 19, 2019
Completion
Sep 24, 2020
Last update
Jan 13, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion